Abstract
The global population is expanding and rapidly aging, with the percentage population over age 65 years expected to double by 2030. This is paralleled by a rise in incidence of cancer and of chronic non-communicable disease. The World Health Organization estimates that newly diagnosed cancers will increase from 14 million to 22 million annually by 2035, with the greatest proportional rise expected in the developing world. Low and middle-income countries (LMICs) will experience 70 % increase in contribution by cancer to disability and premature death. The delivery of cancer care is a global challenge. Surgery remains a mainstay for cancer therapy. Inability to have timely surgical access is estimated to contribute to between 13 and 17 % loss of national global domestic product through loss of workforce productivity in LMIC and high-income countries, respectively, with cancer and injury accounting for more than 95 % of such annual economic welfare loss. In addition to a thorough understanding of cancer therapies and their associated alterations in physiology, it is crucial that perioperative clinicians ensure a safe, complication-free perioperative period for the cancer surgery patient, providing enhanced functional recovery to facilitate continuation of the cancer care journey with adjuvant therapy. Further, our understanding of perioperative perturbations that predispose to tumor spread and recurrence (which may arise from minimal residual disease, circulating tumor cells, or micrometastatic disease) following surgery is rapidly evolving, with the potential opportunity to adapt anesthetic and perioperative strategies. These factors will positively influence long-term cancer outcomes.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
World Health Organization. Ten statistical highlights in global public health. World Health Statistics 2007. http://www.who.int/whosis/whostat2007_10highlights.pdf.
Institute of Medicine. Delivering high-quality cancer care: charting a new course for a system in crisis, vol. 2. Atlanta: National Academies Press; 2013. p. 1.
Kalache A, Keller I. The greying world. A challenge for the twenty-first century. Sci Prog. 2000;83(1):33–54.
Berger NA, Savvides P, Koroukian SM, et al. Cancer in the elderly. Trans Am Clin Climatol Assoc. 2006;117:147–56.
• World Cancer Report 2014. http://www.who.int/mediacentre/factsheets/fs297/en/. Outlines the challenge of the global cancer epidemic.
The Global Economic Cost of Cancer: American Cancer Society. 2010. http://www.cancer.org/acs/groups/content/@internationalaffairs/documents/document/acspc-026203.pdf.
Lennon FE, Mirzapoiazova T, Mambetsariev B, et al. The Mu opioid receptor promotes opioid and growth factor-induced proliferation, migration and epithelial mesenchymal transition (EMT) in human lung cancer. PLoS One. 2014;9(3):e91577. doi:https://doi.org/10.1371/journal.pone.0091577.
Exadaktylos AK, Buggy DJ, Moriarty DC, Mascha E, Sessler DI. Can anesthetic technique for primary breast cancer surgery affect recurrence or metastasis? Anesthesiology. 2006;105(4):660–4.
• Chen W-K, Miao C-H. The effect of anesthetic technique on survival in human cancers: a meta-analysis of retrospective and prospective studies. PLoS One. 2013;8(2):e56540. doi:https://doi.org/10.1371/journal.pone.0056540. A meta-analysis of retrospective studies that support the concept that anaesthetic technique may impact long term cancer outcomes.
Halpern NA. Can the costs of critical care be controlled? Curr Opin Crit Care. 2009;15:591–6.
Popat K, McQueen K, Feeley T. The global burden of cancer. Best Pract Res Clin Anaesthesiol. 2013;27(4):399–408.
Staudinger T, Stoiser B, Mullner M, Locker GJ, Laczika K, Knapp S, et al. Outcome and prognostic factors in critically ill cancer patients admitted to the intensive care unit. Crit Care Med. 2000;28(5):1322–8.
Fischer DJ, Villines D, Kim YO, Epstein JB, Wilkie DJ. Anxiety, depression, and pain: differences by primary cancer. Support Care Cancer. 2010;18(7):801–10.
Krakauer EL, Wenk R, Buitrago R, Jenkins P, Scholten W. Opioid inaccessibility and its human consequences: reports from the field. J Pain Palliat Care Pharmacother. 2010;24(3):239–43.
World health organization. Access to analgesia and to other controlled medications. http://www.who.int/medicines/areas/quality_safety/access_Contr_Med/en/.
Rajagopal MR, Joranson DE. India: opioid availability. An update. J Pain Symptom Manage. 2007;33(5):615–22.
Cherny NI, Baselga J, de Conno F, Radbruch L. Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in Europe: a report from the ESMO/EAPC opioid policy initiative. Ann Oncol. 2010;21(3):615–26.
Kirou-Mauro AM, Hird A, Wong J, Sinclair E, Barnes EA, Tsao M, et al. Has pain management in cancer patients with bone metastases improved? A seven-year review at an outpatient palliative radiotherapy clinic. J Pain Symptom Manage. 2009;37(1):77–84.
Apfelbaum JL, Chen C, Mehta SS, Gan TJ. Postoperative pain experience: results from a national survey suggest postoperative pain continues to be undermanaged. Anesth Analg. 2003;97(2):534–40.
•• Gan TJ, Habib AS, Miller TE, White W, Apfelbaum JL. Incidence, patient satisfaction, and perceptions of post-surgical pain: results from a US national survey. Curr Med Res Opin. 2014,30(1):149–60. Highlights the need to improve perioperative management of surgical pain.
Porter ME. What is value in health care? N Engl J Med. 2010;363(26):2477–81.
Groot MT, Baltussen R, Uyl-de Groot CA, Anderson BO, Hortobágyi GN. Costs and health effects of breast cancer interventions in epidemiologically different regions of Africa, North America, and Asia. Breast J. 2006;12(Suppl 1):S81–90.
Kaplan RS, Porter ME. How to solve the cost crisis in health care. Harv Bus Rev. 2011;89(9):46–52.
Institute of Medicine. Best care at lower cost. http://iom.edu/Reports/2012/Best-Care-at-Lower-Cost-The-Path-to-Continuously-Learning-Health-Care-in-America.aspx.
•• Alkire BC, Shrime MG, Dare AJ, Vincent JR, Meara JG. The global economic consequences of selected surgical diseases: a modelling study. Lancet Glob Health. 2015;3:S21–7. Highlights the need to address global disparity in surgical access and the dire consequences lack of surgical access has on the economic welfare of countries.
Acknowledgments
Dr. Bernhard Riedel wishes to thank Drs. Donal Buggy, Vijaya Gottumukkala, and Erica Sloan for their kind assistance in the development of this issue and the reviewing of the articles.
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is part of the Topical Collection on Cancer Anesthesia.
Rights and permissions
About this article
Cite this article
McQueen, K., Gottumukkala, V., Davies, J.F. et al. Perioperative Implications of the Global Cancer Epidemic. Curr Anesthesiol Rep 5, 243–249 (2015). https://doi.org/10.1007/s40140-015-0123-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40140-015-0123-8